Nanoplastics drive toxicity under co-exposure with perfluorooctanesulfonic acid in human intestinal cellsShow others and affiliations
2025 (English)In: Environmental Chemistry Letters, ISSN 1610-3653, E-ISSN 1610-3661Article in journal (Refereed) Epub ahead of print
Abstract [en]
Per- and polyfluoroalkyl substances and nanoplastics frequently co-occur in environmental matrices, yet the effects of co-exposure on cellular responses upon ingestion are poorly understood. Here, we exposed human intestinal Caco-2 cells to perfluorooctanesulfonic acid, nanoplastics, and their combination. Cell painting-based phenomics was used to map phenotypic alterations across subcellular structures, and untargeted metabolomics using ultra-high-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry was employed to assess metabolic changes. Results show that perfluorooctanesulfonic acid predominantly affected the actin cytoskeleton, Golgi apparatus, and plasma membrane, while nanoplastics primarily targeted mitochondria. Combined exposure disrupted the endoplasmic reticulum, RNA, and mitochondria. Perfluorooctanesulfonic acid reduced levels of carnitines, free fatty acids, nucleotides, and sugars, whereas nanoplastics inhibited ceramides, triglycerides, sphingomyelins, and additional free fatty acids. Combined exposure produced a metabolic profile resembling that of nanoplastics, with specific differences attributed to perfluorooctanesulfonic acid. Overall, nanoplastics appear as the main drivers of the co-exposure effects.
Place, publisher, year, edition, pages
Springer, 2025.
Keywords [en]
Metabolomics, Phenomics, Cell painting, Human intestinal cell line, Perfluorooctanesulfonic acid, Novel exposure biomarkers
National Category
Environmental Sciences
Identifiers
URN: urn:nbn:se:oru:diva-120959DOI: 10.1007/s10311-025-01847-2ISI: 001479534200001Scopus ID: 2-s2.0-105003882258OAI: oai:DiVA.org:oru-120959DiVA, id: diva2:1957286
Funder
Örebro UniversityKnowledge Foundation, 20160019; 20220122; 20230020; 20220086Swedish Research Council, 2022–06725
Note
Open access funding provided by Örebro University. This work was supported by the Swedish Knowledge Foundation [Grants No. 20160019; 20220122, 20230020, 20220086]. We acknowledge scientific support from the Exploring Inflammation in Health and Disease (X‐HiDE) Consortium, which is a strategic research profile at Örebro University funded by the Knowledge Foundation [Grant No. 20200017]. The computations/data handling were partially enabled by resources provided by the National Academic Infrastructure for Supercomputing in Sweden (NAISS), partially funded by the Swedish Research Council [Grant No. 2022–06725, projects NAISS 2024/5–692, and NAISS 2024/6–423].
2025-05-092025-05-092025-05-09Bibliographically approved